Nakeshua A. Roberts v. Commissioner of Social Security

CourtDistrict Court, N.D. Ohio
DecidedNovember 20, 2025
Docket4:25-cv-00764
StatusUnknown

This text of Nakeshua A. Roberts v. Commissioner of Social Security (Nakeshua A. Roberts v. Commissioner of Social Security) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nakeshua A. Roberts v. Commissioner of Social Security, (N.D. Ohio 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION

NAKESHUA A. ROBERTS, ) CASE NO. 4:25-cv-00764-PAB ) Plaintiff, ) JUDGE PAMELA A. BARKER ) v. ) MAGISTRATE JUDGE ) REUBEN J. SHEPERD COMMISSIONER OF ) SOCIAL SECURITY, ) ) REPORT AND RECOMMENDATION Defendant. )

I. Introduction Plaintiff, Nakeshua Roberts (“Roberts”) seeks judicial review of the final decision of the Commissioner of Social Security, denying her application for supplemental security income (“SSI”) under title XVI of the Social Security Act. This matter is before me pursuant to 42 U.S.C. §§ 405(g), 1383(c)(3), and Local Rule 72.2(b). Because the Administrative Law Judge (“ALJ”) applied proper legal standards and reached a decision supported by substantial evidence, I recommend that the Commissioner’s final decision denying Roberts’ application for SSI be affirmed. II. Procedural History Roberts filed for SSI on July 28, 2022, alleging a disability onset date of January 1, 2014. (Tr. 179). The claims were denied initially and on reconsideration. (Tr. 64-72, 74-82). She then requested a hearing before an ALJ. (Tr. 115). Roberts (represented by counsel) and a vocational expert (“VE”) testified before the ALJ on January 22, 2024. (Tr. 32-62). On February 12, 2024, the ALJ issued a written decision finding Roberts not disabled. (Tr. 14-27). The Appeals Council denied her request for review on February 10, 2025, making the hearing decision the final decision of the Commissioner. (Tr. 1-3; see 20 C.F.R. §§ 404.955, 404.981). Roberts timely filed this action on April 16, 2025. (ECF Doc. 1). III. Evidence

A. Personal, Educational, and Vocational Evidence Roberts was 48 years old on her application date, making her a younger individual according to Agency regulations. (See Tr. 26). She graduated from high school. (See id.). In the past, she worked as a customer service representative, and as a hair and nail technician. (Tr. 25). B. Relevant Medical Evidence1 On May 29, 2020, Roberts presented to Heather Dawson, APRN-CNP for mental health treatment of her anxiety, depression, and bipolar disorder. (Tr. 518-22). Roberts reported anxiety ranging from seven to ten out of ten, and having two panic attacks that week. (Tr. 518). She denied suicidal or homicidal ideations, although she also acknowledged some thoughts of self-

harm and was hiding sharp objects from herself and her son. (Id.). She reported PTSD symptoms, including nightmares, flashbacks, anger, irritability, and hypervigilance. (Tr. 519). On examination, Roberts had poor insight, judgment, attention span, and concentration, but findings were otherwise normal. (Id.). CNP Dawson recommended Roberts attend an assessment to start counseling, and to follow up with her primary care doctor for physical symptoms. (Id.). She continued Roberts on Klonopin 1 mg three times daily (with plan to wean); Latuda 60 mg

1 Roberts only raises error with the ALJ’s consideration of her mental health limitations in forming the RFC. (See ECF Doc. 7, pp. 8-14). All other issues are deemed waived. See Swain v. Comm’r of Soc. Sec., 379 F. App’x 512, 517 (6th Cir. 2010) (affirming a district court’s finding that a claimant waived arguments that he did not raise in his merits brief). I therefore only provide a review of the relevant mental health evidence; I do not provide review of physical medical evidence, e.g., of Roberts’ fibromyalgia or back pain. for mood stabilization; Vistaril 50 mg three times daily, as needed for breakthrough anxiety; Lamictal 150 mg; and Benztropine 1 mg twice daily, for restlessness. (Id.). On October 4, 2021, Roberts followed with Kimothy Kane, APRN-CNP for medication management. (Tr. 563-72). She reported that her anxiety and depression had been stable when she takes her medications. (Tr. 553). She rated her anxiety at eight on a ten-point scale and her

depression at ten on a ten-point scale. (Id.). She reported feelings of guilt, low self-worth, feeling down and depressed, hopeless, having little interest and pleasure in doing things, and poor appetite, and crying spells. (Id.). She denied suicidal and homicidal ideations, paranoia, and audio or visual hallucinations. (Id.). On examination, CNP Kane noted anhedonia and that Roberts was anxious, and that she had poor sleep; all other examination results were noted as normal. (Tr. 555). CNP Kane continued all medications. (Tr. 571-72). On November 2, 2021, Roberts followed with CNP Kane for medication management. (Tr. 553-62). She reported that she was working to regulate her son’s medications and once that was accomplished she would have more stable moods herself. (Tr. 563). She rated her anxiety at

nine on a ten-point scale. (Id.). She denied suicidal ideation, paranoia, and audio or visual hallucinations. (Id.). On examination, CNP Kane noted anhedonia and that Roberts was anxious; all other examination results were noted as normal. (Tr. 565). CNP Kane continued all medications. (Tr. 571-72). On December 2, 2021, Roberts followed with CNP Kane for medication management. (Tr. 542-51). She reported that she was recovering from COVID-19 and had missed her medications during her illness. (Tr. 542). She reported feelings of guilt, low self-worth, feeling down and depressed, hopeless, having little interest and pleasure in doing things, poor appetite, and crying spells. (Id.). She denied suicidal and homicidal ideations, paranoia, and audio or visual hallucinations. (Id.). On examination, CNP Kane noted anhedonia and that Roberts was anxious, and that her recovery from COVID-19 had elevated her depression and anxiety; all other examination results were noted as normal. (Tr. 544). CNP Kane continued all medications. (Tr. 544-45). On December 30, 2021, Roberts followed with CNP Kane for medication management.

(Tr. 531-41). She reported anxiety ranging from nine to ten out of ten, and having daily panic attacks lasting five minutes. (Tr. 531). She reported feelings of guilt, low self-worth, feeling down and depressed, hopeless, having little interest and pleasure in doing things, poor appetite, and crying spells. (Id.). She denied suicidal and homicidal ideations and paranoia but reported seeing things in her peripheral vision. (Id.). She was getting poor, broken sleep with nightmares. (Id.). On examination, CNP Kane noted anhedonia and that Roberts was anxious; all other examination results were noted as normal. (Tr. 533). CNP Kane continued all medications. (Tr. 533-34). On March 7, April 8, and June 22, 2022, Roberts followed up with CNP Kane for

medication management. (Tr. 602-22). Roberts reported her functioning was not difficult; she rated depression and anxiety up to ten on a ten-point scale; she had panic attacks at times, lasting for a few minutes up to an hour. (Tr. 602, 609, 616). On examination, CNP Kane noted anhedonia and hallucinations, and that Roberts was anxious; all other examination results were noted as normal. (Tr. 603, 610, 617). Roberts reported symptom improvements and that she was able to handle life stressors. (Tr. 607). CNP Kane continued all medications. (Tr. 607, 614, 621). On July 19, 2022, Roberts followed up with CNP Kane for medication management. (Tr. 594-601). Roberts reported depression and anxiety as a ten on a ten-point scale; she had panic attacks which she was controlling but her anxiety attacks often required an emergency department visit. (Tr. 594). On examination, CNP Kane noted hallucinations, anhedonia, and that Roberts was anxious; all other examination results were noted as normal. (Tr. 595). CNP Kane decreased Seroquel for sleep but continued all other medications. (Tr. 600).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Angela M. Jones v. Commissioner of Social Security
336 F.3d 469 (Sixth Circuit, 2003)
Barbara Combs v. Commissioner of Social Security
459 F.3d 640 (Sixth Circuit, 2006)
David Bowen v. Commissioner of Social Security
478 F.3d 742 (Sixth Circuit, 2007)
Debra Rogers v. Commissioner of Social Security
486 F.3d 234 (Sixth Circuit, 2007)
Fleischer v. Astrue
774 F. Supp. 2d 875 (N.D. Ohio, 2011)
Walton v. Astrue
773 F. Supp. 2d 742 (N.D. Ohio, 2011)
Doris Poe v. Commissioner of Social Security
342 F. App'x 149 (Sixth Circuit, 2009)
David Swain v. Commissioner of Social Security
379 F. App'x 512 (Sixth Circuit, 2010)
Anthony Reeves v. Comm'r of Social Security
618 F. App'x 267 (Sixth Circuit, 2015)
Biestek v. Berryhill
587 U.S. 97 (Supreme Court, 2019)
United States v. Patrick Wandahsega
924 F.3d 868 (Sixth Circuit, 2019)
Randy Berkshire v. Debra Dahl
928 F.3d 520 (Sixth Circuit, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Nakeshua A. Roberts v. Commissioner of Social Security, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nakeshua-a-roberts-v-commissioner-of-social-security-ohnd-2025.